HRP20130985T1 - Protu-upalne djelatne tvari u euganejskom termalnom blatu - Google Patents
Protu-upalne djelatne tvari u euganejskom termalnom blatu Download PDFInfo
- Publication number
- HRP20130985T1 HRP20130985T1 HRP20130985TT HRP20130985T HRP20130985T1 HR P20130985 T1 HRP20130985 T1 HR P20130985T1 HR P20130985T T HRP20130985T T HR P20130985TT HR P20130985 T HRP20130985 T HR P20130985T HR P20130985 T1 HRP20130985 T1 HR P20130985T1
- Authority
- HR
- Croatia
- Prior art keywords
- acid
- unsaturated
- saturated
- use according
- mixture
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title claims 3
- 239000002253 acid Substances 0.000 claims 21
- 239000000203 mixture Substances 0.000 claims 9
- 229920006395 saturated elastomer Polymers 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 230000007170 pathology Effects 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical group 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 2
- FROLUYNBHPUZQU-IIZJPUEISA-N (2R,3R,4S,5R)-2-(hydroxymethyl)-6-[3-[3-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropoxy]propoxy]oxane-3,4,5-triol Chemical compound OC[C@H]1OC(OCCCOCCCOC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O FROLUYNBHPUZQU-IIZJPUEISA-N 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (6)
1. Uporaba glikolipida izabranih iz grupe koja obuhvaća:
a) monogalaktozildigliceride koji sadrže smjesu zasićenih i nezasićenih masnih kiselina s između 14 i 18 atoma ugljika naznačeno time što ta smjesa sadrži barem 45% zasićene C16 kiseline i barem 25% tetra-nezasićene C18 kiseline,
b) digalaktozildiglicerid koji sadrži smjesu zasićenih i nezasićenih masnih kiselina s između 14 i 18 atoma ugljika, naznačeno time što ta smjesa sadrži barem 45% zasićene C16 kiseline i barem 20 % tetra-nezasićene C18 kiseline, i
c) smjesu (a) i (b)
za pripremu lijeka koji ima protu-upalni učinak, taj lijek ih sadrži kao djelatne tvari.
2. Uporaba prema zahtjevu 1, naznačena time što smjese (a) imaju sljedeći sastav masnih kiselina (a’):
između 1.5% i 2.5% zasićene C14 kiseline;
između 45% i 55% zasićene C16 kiseline;
između 1.5% i 2.5% mono-nezasićene C16 kiseline;
između 3% i 4.5% mono-nezasićene C18 kiseline;
između 1.5% i 2.5% di-nezasićene C18 kiseline;
između 8% i 9% tri-nezasićene C18 kiseline;
između 25% i 35% tetra-nezasićene C18 kiseline.
3. Uporaba prema zahtjevu 1, naznačena time što smjese (b) imaju sljedeći sastav masnih kiselina (b’):
između 0 % i 1% zasićene C14 kiseline;
između 45% i 55% zasićene C16 kiseline;
između 2.5% i 3.5% mono-nezasićene C16 kiseline;
između 0% i 1% di-nezasićene C16 kiseline;
između 0% i 1% tri-nezasićene C16 kiseline;
između 1% i 2% zasićene C18 kiseline;
između 1.5% i 2.5% mono-nezasićene C18 kiseline;
između 3.5% i 4.5% di-nezasićene C18 kiseline;
između 10% i 12% tri-nezasićene C18 kiseline;
između 20% i 30% tetra-nezasićene C18 kiseline.
4. Uporaba prema bilo kojem od zahtjeva 1-3, gdje se navedeni lijek koji ima protu-upalni učinak koristi u liječenju upalnih patologija.
5. Uporaba prema zahtjevu 4, gdje su upalne patologije koštano-zglobne patologije.
6. Uporaba prema bilo kojem od zahtjeva 1-5, gdje je navedeni lijek prikladan za primjenu na kožu.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000011A ITMI20040011A1 (it) | 2004-01-09 | 2004-01-09 | Principi attivi antiinfiammatori nei fanghi termali euganei |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130985T1 true HRP20130985T1 (hr) | 2013-11-22 |
Family
ID=34746697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130985TT HRP20130985T1 (hr) | 2004-01-09 | 2013-10-17 | Protu-upalne djelatne tvari u euganejskom termalnom blatu |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1571203B1 (hr) |
| ES (1) | ES2431117T3 (hr) |
| HR (1) | HRP20130985T1 (hr) |
| IT (1) | ITMI20040011A1 (hr) |
| SI (1) | SI1571203T1 (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1393093B1 (it) | 2009-02-18 | 2012-04-11 | Bluegreen Biotech S R L | Miscela glicolipidica da oscillatoria planktothrix con attivita' immunomodulante ed antiinfiammatoria |
| ITPD20100209A1 (it) * | 2010-07-07 | 2012-01-08 | Ct Studi Termali Veneto Pietro D Abano Di Aban | Procedimento per la preparazione su larga scala di un cianobatterio del genere phormidium del fango termale euganeo |
| EP2641607A1 (en) | 2012-03-21 | 2013-09-25 | Sanofi | A mixture of polar glycolipids for use in the treatment of pain and COPD |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4913289B2 (ja) * | 2001-05-23 | 2012-04-11 | 備前化成株式会社 | カスパーゼ阻害剤 |
-
2004
- 2004-01-09 IT IT000011A patent/ITMI20040011A1/it unknown
-
2005
- 2005-01-05 EP EP05100038.8A patent/EP1571203B1/en active Active
- 2005-01-05 ES ES05100038T patent/ES2431117T3/es active Active
- 2005-01-05 SI SI200531788T patent/SI1571203T1/sl unknown
-
2013
- 2013-10-17 HR HRP20130985TT patent/HRP20130985T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1571203A2 (en) | 2005-09-07 |
| ITMI20040011A1 (it) | 2004-04-09 |
| EP1571203B1 (en) | 2013-07-24 |
| ES2431117T3 (es) | 2013-11-25 |
| EP1571203A3 (en) | 2006-01-25 |
| SI1571203T1 (sl) | 2013-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
| AR114051A2 (es) | Composiciones farmacéuticas y supositorio vaginal | |
| PH12021550328A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
| UY29321A1 (es) | Piperazinilureas y piperidinilureas como moduladores de hidrolasa de amida de ácidos grasos | |
| JP2013082950A5 (hr) | ||
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| MY189770A (en) | Biaryl derivative as gpr120 agonists | |
| DK2007214T3 (da) | Spiselige produkter med lavt indhold af mættede og trans-umættede fedter | |
| EA200100895A1 (ru) | Незаменимые жирные кислоты для предотвращения сердечно-сосудистых приступов | |
| WO2007022897A8 (en) | Non-hydrogenated hardstock fat | |
| ZA200802678B (en) | Non-hydrogenated hardstock fat | |
| HRP20221325T1 (hr) | Pripravci i postupci transmukozne apsorpcije | |
| HRP20130985T1 (hr) | Protu-upalne djelatne tvari u euganejskom termalnom blatu | |
| HRP20160203T1 (hr) | Pripravci koji sadrže 15-hepe i postupci njihove upotrebe | |
| PT1296670E (pt) | Combinacoes terapeuticas de acidos gordos | |
| JP2016512245A5 (ja) | マイボーム腺を標的とする組成物 | |
| WO2008149951A1 (ja) | 透明固形石鹸 | |
| HRP20191963T1 (hr) | Smjesa masnih kiselina za primjenu u liječenju upalnih patologija | |
| NO20076382L (no) | Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer | |
| RU2014102958A (ru) | Сложные эфиры для лечения офтальмологических воспалительных заболеваний | |
| NZ593186A (en) | Fatty acids derived from hydrolysing triglycerides for inducing defecation | |
| JP2008540484A5 (hr) | ||
| HRP20201221T1 (hr) | Sastavi omega 3 masnih kiselina za liječenje bolesti koje uključuju štete nastale u živčanom sustavu | |
| RU2009148576A (ru) | Экструдаты с улучшенной маскировкой вкуса | |
| Strokin et al. | Proinflammatory treatment of astrocytes with lipopolysaccharide results in augmented Ca2+ signaling through increased expression of via phospholipase A2 (iPLA2) |